The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
MMP13 is a critical target gene during the progression of osteoarthritis
Open accessAbstract
Introduction: Osteoarthritis (OA) is a degenerative joint disease affecting a large population of people. The mechanism of this highly prevalent disease is not fully understood. Currently there is no effective disease-modifying treatment for OA. The purpose of this study was two-fold: 1) to investigate the role of MMP13 in the development of OA; and 2) to evaluate the efficacy of the MMP13 inhibitor CL82198 as a pharmacologic treatment for preventing OA progression. Methods: To investigate the role of the endogenous Mmp13 gene in OA development, tamoxifen was administered to two-week-old Col2CreER;Mmp13 fx/fx ( Mmp13 Col2ER ) and Cre-negative control mice for five days. OA was induced by meniscal-ligamentous injury (MLI) when the mice were 10 weeks old and MLI or sham-operated joints were harvested 4, 8, 12, or 16 weeks after surgery. To evaluate the efficacy of CL82198, MLI surgery was performed on 10-week-old wild type mice. CL82198 or saline was administered to the mice daily beginning immediately after the surgery for up to 16 weeks. The joint tissues collected from both experiments were evaluated by cartilage grading, histology/histomorphometry, immunohistochemistry (IHC), and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The ability of CL82198 to inhibit MMP13 activity in vitro was confirmed by ELISA. Results: The OA progression was decelerated in Mmp13 Col2ER mice 8, 12, and 16 weeks post-surgery. Cartilage grading by blinded observers confirmed decreased articular cartilage degeneration in Mmp13 Col2ER mice at 8, 12 and 16 weeks compared to Cre-negative mice. Histomorphometric analysis demonstrated that Mmp13 Col2ER mice had a higher articular cartilage area and thickness at 12 and 16 weeks post-surgery compared to the control mice. Results of IHC revealed greater type II collagen and proteoglycan expression in Mmp13 Col2ER mice. Chondrocyte apoptosis, as determined by TUNEL staining, was higher in control mice compared to Mmp13 Col2ER mice. CL82198 inhibited MMP13 activity in conditioned media from vehicle (> 85%) or bone morphogenetic protein 2 (BMP2)-treated (> 90%) primary murine sternal chondrocytes. Intraperitoneal injection of CL82198 decelerated MLI-induced OA progression, increased type II collagen and proteoglycan levels, and inhibited chondrocyte apoptosis compared to saline treatment as determined by OA grading, histology, histomorphometry, IHC, and TUNEL staining, respectively. Conclusions: Mmp13 is critical for OA progression and pharmacologic inhibition of MMP13 is an effective strategy to decelerate articular cartilage loss in a murine model of injury-induced knee OA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
Glasson, S. S., Askew, R., Sheppard, B., Carito, B., Blanchet, T., Ma, H.-L., Flannery, C. R., Peluso, D., Kanki, K., Yang, Z., et al. (2005) · Nature · doi:10.1038/nature03369 · Cited by 1,253
Goldring, M. B., & Goldring, S. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21258 · Cited by 1,179
Vincenti, M. P., & Brinckerhoff, C. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar401 · Cited by 796
Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., & Thompson, E. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25002 · Cited by 642
Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathology
Blanco, F. J., Guitian, R., V�zquez-Martul, E., de Toro, F. J., & Galdo, F. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199802)41:2<284::aid-art12>3.0.co;2-t · Cited by 604
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice
Stickens, D., Behonick, D. J., Ortega, N., Heyer, B., Hartenstein, B., Yu, Y., Fosang, A. J., Schorpp-Kistner, M., Angel, P., & Werb, Z. (2004) · Development · doi:10.1242/dev.01461 · Cited by 604
Inada, M., Wang, Y., Byrne, M. H., Rahman, M. U., Miyaura, C., López-Otín, C., & Krane, S. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407788101 · Cited by 575
Neuhold, L. A., Killar, L., Zhao, W., Sung, M.-L. A., Warner, L., Kulik, J., Turner, J., Wu, W., Billinghurst, C., Meijers, T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10564 · Cited by 540
Hunter, D. J., Zhang, Y. Q., Niu, J. B., Tu, X., Amin, S., Clancy, M., Guermazi, A., Grigorian, M., Gale, D., & Felson, D. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21724 · Cited by 517
Matrix Metalloproteinase Inhibitor Development and the Remodeling of Drug Discovery
Peterson, J. T. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011395.11179.af · Cited by 370
Roach, H. I., Yamada, N., Cheung, K. S. C., Tilley, S., Clarke, N. M. P., Oreffo, R. O. C., Kokubun, S., & Bronner, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21300 · Cited by 351
Characterization of and osteoarthritis susceptibility in ADAMTS‐4–knockout mice
Glasson, S. S., Askew, R., Sheppard, B., Carito, B. A., Blanchet, T., Ma, H., Flannery, C. R., Kanki, K., Wang, E., Peluso, D., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20558 · Cited by 281
Shiomi, T., Lemaître, V., D'Armiento, J., & Okada, Y. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02547.x · Cited by 274
Chondrocyte death by apoptosis is associated with cartilage matrix degradation
Thomas, C. M., Fuller, C. J., Whittles, C. E., & Sharif, M. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.06.012 · Cited by 248
Clements, K. M., Price, J. S., Chambers, M. G., Visco, D. M., Poole, A. R., & Mason, R. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11355 · Cited by 215
Wang, M., Shen, J., Jin, H., Im, H., Sandy, J., & Chen, D. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06258.x · Cited by 202
Self-citationPETERSON, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.032 · Cited by 196
Baragi, V. M., Becher, G., Bendele, A. M., Biesinger, R., Bluhm, H., Boer, J., Deng, H., Dodd, R., Essers, M., Feuerstein, T., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24629 · Cited by 174
Sharif, M., Whitehouse, A., Sharman, P., Perry, M., & Adams, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20020 · Cited by 172
New molecular targets for the treatment of osteoarthritis
Alcaraz, M. J., Megías, J., García-Arnandis, I., Clérigues, V., & Guillén, M. I. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.017 · Cited by 154
Ding, C., Martel‐Pelletier, J., Pelletier, J., Abram, F., Raynauld, J., Cicuttini, F., & Jones, G. (2007) · PubMed · Cited by 154
Chen, M., Lichtler, A. C., Sheu, T., Xie, C. L., Zhang, X., O’Keefe, R. J., & Chen, D. (2007) · genesis · doi:10.1002/dvg.20261 · Cited by 140
Self-citationRíos, M. H., Sorsa, T. A., Obregón, F., Tervahartiala, T. I., Valenzuela, M. A., Pozo, P., Dutzan, N., Lesaffre, E. M. E. H., Molas, M., & Gamonal, J. A. (2009) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01488.x · Cited by 108
Chen, J., Nelson, F. C., Levin, J. I., Mobilio, D., Moy, F. J., Nilakantan, R., Zask, A., & Powers, R. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001547g · Cited by 108
Smad1 plays an essential role in bone development and postnatal bone formation
Wang, M., Jin, H., Tang, D.-Z., Huang, S., Zuscik, M. J., & Chen, D. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.03.004 · Cited by 67
Self-citation
Cited by
Martel-Pelletier, J., Barr, A. J., Cicuttini, F. M., Conaghan, P. G., Cooper, C., Goldring, M. B., Goldring, S. R., Jones, G., Teichtahl, A. J., & Pelletier, J.-P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.72 · Cited by 1,877
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Self-citationOsteoarthritis: pathogenic signaling pathways and therapeutic targets
Yao, Q., Wu, X., Tao, C., Gong, W., Chen, M., Qu, M., Zhong, Y., He, T., Chen, S., & Xiao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01330-w · Cited by 1,194
Osteoarthritis: toward a comprehensive understanding of pathological mechanism
Chen, D., Shen, J., Zhao, W., Wang, T., Han, L., Hamilton, J. L., & Im, H.-J. (2017) · Bone Research · doi:10.1038/boneres.2016.44 · Cited by 1,187
Self-citationGoldring, S. R., & Goldring, M. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.148 · Cited by 896
Metadata
- Authors
- Wang, M., Sampson, E. R., Jin, H., Li, J., Ke, Q. H., Im, H.-J., & Chen, D.
- Venue
- Arthritis Research & Therapy
- Published
- 2013-01-08
- Volume
- 15
- Issue
- 1
- Pages
- R5-R5
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2106582491
- Cited by
- 508
- References
- 25
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.